文献速递生殖医学妇科产科

2021年男女生育力保存:现状与挑战

Fertility preservation in men and women: Where are we in 2021? Are we rising to the challenge?
PubMed 文献 · Fertil Steril · 2021-04-03

女性因肿瘤、非肿瘤及个人原因对生育力保存的需求急剧增加,卵母细胞冷冻和卵巢组织冷冻均获美国生殖医学会认可且疗效得到证实;白血病或癌症转移高风险且不适合卵巢组织移植者只能通过体外方法恢复生育力,男性生育力保存也成为紧迫议题。

要点

  • 卵母细胞冷冻和卵巢组织冷冻均获美国生殖医学会认可,疗效已获多篇论文证实
  • 白血病或癌症患者卵巢转移风险高、不适合卵巢组织移植时,只能通过体外方法恢复生育力
  • 男性生育力保存已成为紧迫议题

核心结论

  • 女性生育力保存需求急剧增加,现有方法(卵母细胞冷冻和卵巢组织冷冻)已获认可且有效,但特定高风险患者仍需体外方法。

研究设计与样本

  • 本文为综述,总结2021年男女生育力保存的现状与挑战。

主要发现

  • 女性因肿瘤、非肿瘤及个人原因对生育力保存的需求急剧增加。
  • 卵母细胞冷冻和卵巢组织冷冻均获美国生殖医学会认可,多篇论文证实其疗效。
  • 白血病或癌症患者卵巢转移风险高且可能不适合卵巢组织移植时,只能通过体外方法恢复生育力。
  • 男性生育力保存已成为紧迫议题,本刊本期有广泛综述。

临床怎么用

  • 对需要生育力保存的女性,可考虑卵母细胞冷冻或卵巢组织冷冻;对卵巢转移高风险且不适合卵巢组织移植者,应探索体外方法。
  • 男性生育力保存应作为紧迫议题纳入临床考量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Demand for fertility preservation in women for oncologic, nononcologic, and personal reasons has increased dramatically. Meeting that demand is a major challenge, and we are rising to the challenge. Mature oocyte cryopreservation after ovarian stimulation and ovarian tissue cryopreservation are both methods endorsed by the American Society for Reproductive Medicine (formerly The American Fertility Society), and numerous papers confirmed their efficacy. In girls and women with leukemia or cancers who are at a high risk of ovarian metastasis and who may not be eligible for ovarian tissue transplantation, restoration of fertility can only be achieved by in vitro methods. Male fertility preservation has also become a pressing issue and is extensively reviewed in the present journal issue.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Donnez J, Dolmans MM. Fertility preservation in men and women: Where are we in 2021? Are we rising to the challenge? Fertil Steril. 2021. PMID: 33823991. doi:10.1016/j.fertnstert.2021.03.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。